Skip to main content

CITIGROUP INC

Position in KROS — Keros Therapeutics, Inc.

CIK 831001 NEW YORK, NY

Position in KROS

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$96,459
+$72,083 QoQ
Shares Held
9,015
+308.3% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 131 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Derivatives in KROS

reported options exposure · as of Sep 30, 2024
CallValue
$818,787
CallShares
14,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. KROS ranks #256 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $96,459 9,015
2026-03-31 $24,376 2,208
2025-12-31 $144,738 7,109
2025-09-30 $46,146 2,917
2025-06-30 $458,958 34,379
2025-03-31 $731,202 71,757
2024-12-31 $861,515 54,423
2024-09-30 $1,357,734 23,381
2024-09-30 $818,787 14,100
2024-06-30 $575,042 12,583
2024-03-31 $7,775,586 117,456
2023-12-31 $6,734,986 169,391
2023-09-30 $3,127,714 98,109
2023-06-30 $6,141,392 152,847
2023-03-31 $13,922,932 326,064
2022-12-31 $19,789,186 412,103
2022-09-30 $17,911,747 476,123
2022-06-30 $12,775,283 462,370
2022-03-31 $428,078 7,872
2021-12-31 $1,879,341 32,120
2021-09-30 $735,895 18,602
2021-06-30 $1,764,373 41,544
2021-03-31 $2,628,000 42,697
2020-12-31 $233,205 3,306
2020-09-30 $12,920 335
2020-06-30 $35,371 943